诊断为慢性淋巴细胞白血病的患者死亡原因:荷兰的一项基于人口的研究,1996-2020年
Lina van der Straten1,2,3, Mark-David Levin2, Manette A W Dinnessen1
1Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands.
HemaSphere
|November 13, 2024
概括
慢性淋巴细胞白血病 (CLL) 死亡人数显著下降,CLL仍然是导致死亡的主要原因. 这一趋势凸显了对CLL持续的临床策略和研究的需要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 呈现出不同的临床结果.
- 了解CLL死亡原因 (COD) 对患者管理至关重要.
研究的目的:
- 为了分析大量基于人口的CLL患者队列中的COD.
- 评估随着时间的推移与CLL和其他原因相关的死亡率趋势.
主要方法:
- 使用因果特定的灵活参数生存模型.
- 分析了20,588名在1996年至2020年期间在荷兰被诊断为CLL患者的数据.
- 估计的因果特异性危险比率 (HRs) 和累计发生率.
主要成果:
- 淋巴结核炎是主要的COD,约占相对死亡率的40%.
- 观察到5年死亡概率的显著下降,从16.8% (1996-2002) 降至7.6% (2010-2020).
- 由于固体恶性瘤,其他血液性恶性瘤和其他原因的死亡率也下降了.
结论:
- 在1996年至2020年期间,CLL导致的死亡和相应原因的显着减少发生了.
- 在被诊断的患者中,CLL仍然是死亡的主要原因.
- 持续专注于CLL特定的临床策略和研究至关重要.
相关概念视频
Disorders of Leukocytes
865
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
865
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


